← Oncology Approval Tracker

FDA DECISION ·

Bortezomib for Injection (Hospira)

bortezomib · Hospira

FDA approvalNew or expanded indicationMantle cell lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adult mantle cell lymphoma added to the label for the specified Hospira bortezomib-for-injection product.

LAMPGEN ANALYSIS

Why it matters

The decision extends the labeled use of this product to a second hematologic malignancy.

What research teams should watch

Record the product identity and diagnosis when incorporating the additional indication into ordering workflows.

PRIMARY RECORDS

Sources